# Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude

> **NCT02024386** · PHASE4 · COMPLETED · sponsor: **Richard Moon** · enrollment: 28 (actual)

## Conditions studied

- Hypertension, Pulmonary
- Altitude Sickness

## Interventions

- **DRUG:** Riociguat

## Key facts

- **NCT ID:** NCT02024386
- **Lead sponsor:** Richard Moon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024386, "Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT02024386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*